Consolidated Statement of Stockholders' Equity - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Beginning balance, shares at Dec. 31, 2018	27,364,607
Beginning balance, amount at Dec. 31, 2018	$ 2,736	$ 16,791,254	$ (4,404,336)	$ 0	$ 12,389,654
Sale of common stock and warrants at $6.50 per share and placement agent warrants in public offering, net of issuance costs, shares	1,923,076
Sale of common stock and warrants at $6.50 per share and placement agent warrants in public offering, net of issuance costs, amount	$ 192	11,351,022			11,351,214
Common shares issued upon exercise of warrants at $3.00 per share, shares	127,649
Common shares issued upon exercise of warrants at $3.00 per share, amount	$ 13	382,934			382,947
Common shares issued upon exercise of warrants at $5.00 per share, net of issuance costs, shares	345,834
Common shares issued upon exercise of warrants at $5.00 per share, net of issuance costs, amount	$ 35	1,700,469			1,700,504
Common shares issued upon exercise of stock options, shares	38,750
Common shares issued upon exercise of stock options, amount	$ 4	58,121			58,125
Share-based compensation expense		1,536,096			1,536,096
Net unrealized gain on short-term investments					0
Common shares issued for services, shares	30,000
Common shares issued for services, amount	$ 3	102,597			102,600
Net loss for the period			(8,325,488)		(8,325,488)
Ending balance, shares at Dec. 31, 2019	29,829,916
Ending balance, amount at Dec. 31, 2019	$ 2,983	31,922,493	(12,729,824)	0	19,195,652
Sale of common stock and warrants at $6.00 per share and placement agent warrants in public offering, net of issuance costs, shares	2,066,667
Sale of common stock and warrants at $6.00 per share and placement agent warrants in public offering, net of issuance costs, amount	$ 207	11,666,999			11,667,206
Common shares issued upon exercise of warrants at $3.00 per share, shares	328,458
Common shares issued upon exercise of warrants at $3.00 per share, amount	$ 33	960,993			961,026
Common shares issued upon exercise of warrants at $5.00 per share, net of issuance costs, shares	3,890,839
Common shares issued upon exercise of warrants at $5.00 per share, net of issuance costs, amount	$ 389	18,718,605			18,718,994
Common shares issued uppon exercise of warrants at $6.00 per share, net of issuance costs, shares	675,000
Common shares issued uppon exercise of warrants at $6.00 per share, net of issuance costs, amount	$ 68	3,847,432			3,847,500
Common shares issued uppon exercise of warrants at $6.50 per share, net of issuance costs, shares	261,679
Common shares issued uppon exercise of warrants at $6.50 per share, net of issuance costs, amount	$ 26	1,646,292			1,646,318
Common shares issued upon exercise of stock options, shares	371,000
Common shares issued upon exercise of stock options, amount	$ 37	705,313			705,350
Common shares issued upon vesting of restricted stock units, shares	130,603
Common shares issued upon vesting of restricted stock units, amount	$ 13	(13)			0
Share-based compensation expense		2,236,743			2,236,743
Net unrealized gain on short-term investments				14,849	14,849
Net loss for the period			(12,580,209)		(12,580,209)
Ending balance, shares at Dec. 31, 2020	37,554,162
Ending balance, amount at Dec. 31, 2020	$ 3,756	$ 71,704,857	$ (25,310,033)	$ 14,849	$ 46,413,429